The global moderate-to-severe acne treatment market was valued at US$ 1.2 Billion in 2022 and is expected to reach US$ 2.4 Billion by 2033. The retinoid therapy with around 25.6% value share, has topped the global market within the treatment category in 2022 and is expected to grow at a CAGR of close to 6.5% over the forecast period (2023 to 2033)
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 1.2 Billion |
| Market Value 2023 | US$ 1.3 Billion |
| Market Value 2033 | US$ 2.4 Billion |
| CAGR 2023 to 2033 | 6.5% |
| Market Share of Top 5 Countries | 57.4% |
| Key Market Players | Johnson & Johnson, Bayer AG, Galderma, Allergan, Roche, Valeant Pharmaceuticals, Stiefel Laboratories, Pfizer, Foamix Pharmaceuticals, La Roche-Posay, Proactiv, Cipla Limited, GlaxoSmithKline, Janssen Pharmaceuticals Inc. & Sanofi. |
Acne is a prevalent skin condition, affecting millions of people worldwide. The incidence of moderate-to-severe acne has been increasing, driven by factors such as hormonal changes, lifestyle habits, and genetic predisposition. This growing prevalence fuels the demand for effective treatments.
There is a growing awareness among individuals about the impact of acne on their appearance and quality of life. More people with moderate-to-severe acne are seeking professional treatment and are willing to invest in products and therapies to address their condition, driving market growth.
Economic growth and rising disposable incomes in many regions have led to increased healthcare spending. Individuals are willing to invest in premium skincare products, dermatology consultations, and advanced acne treatments. This trend boosts the demand for moderate-to-severe acne treatment products and therapies.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for moderate-to-severe acne treatment was around 12.5% of the overall US$ 9.6 Billion of the global acne treatment market in 2022.
There is a growing demand for effective treatments for moderate-to-severe acne. Individuals with more severe forms of acne often seek professional help and are willing to invest in products and therapies that can provide significant improvement. The increasing awareness and social impact of acne drive the demand for treatments, contributing to sales growth.
Advancements in acne treatment have led to more effective therapies for moderate-to-severe acne. New ingredients, formulations, and delivery systems enhance treatment outcomes and reduce the severity and duration of acne lesions. The improved efficacy of treatments increases patient satisfaction and contributes to sales growth.
Increased awareness about the impact of acne on physical appearance and quality of life has led individuals to seek professional treatment. Educational campaigns and information dissemination through various media platforms have improved awareness about the availability of effective treatments for moderate-to-severe acne. This increased awareness has driven sales growth in the market.
Owed to the above factors, the global market is projected to grow at CAGR of 6.5% in forecasted period.
There is huge opportunity for market players to develop and introduce advanced treatment modalities for moderate-to-severe acne. This includes exploring innovative technologies such as laser therapies, light-based treatments, chemical peels, and photodynamic therapy. Advancements in these modalities provide more effective and efficient acne treatment options, attracting both patients and healthcare professionals.
Combination therapies involving the use of multiple treatment modalities or a combination of medications offer an opportunity for improved outcomes in moderate-to-severe acne treatment. By combining different therapeutic approaches, such as topical medications, oral medications, and physical treatments, synergistic effects can be achieved, leading to better efficacy and patient satisfaction.
The demand for skincare products specifically formulated for moderate-to-severe acne presents an opportunity for new product development. This includes the development of non-comedogenic, oil-free, and acne-fighting skincare products that address the unique needs of individuals with moderate-to-severe acne. Targeted skincare products can complement medical treatments and improve overall outcomes.
The integration of telemedicine and digital health solutions in acne treatment offers opportunities for remote consultations, follow-up care, and patient monitoring. Telemedicine platforms can enable access to specialized dermatological care, particularly in underserved areas. Digital health tools, such as mobile applications for acne tracking and management, can enhance patient engagement and treatment adherence.
Principal Consultant
The cost of moderate-to-severe acne treatments, including prescription medications and procedures, can be a significant barrier for some individuals. Expensive treatments may not be accessible or affordable for all patients, limiting their options for effective acne management. The cost-effectiveness of treatments and insurance coverage play crucial roles in addressing this restraint.
Access to specialized dermatological care can be limited in some regions or underserved areas. The availability of dermatologists and specialized clinics may be scarce, making it challenging for individuals with moderate-to-severe acne to receive timely and appropriate treatment. Improving access to dermatological care is essential to address this restraint.
Antibiotics are commonly used in the treatment of moderate-to-severe acne, but antibiotic resistance is a growing concern. Prolonged or inappropriate use of antibiotics can contribute to the development of resistant bacteria, reducing treatment efficacy and limiting future treatment options. Finding alternative approaches to acne treatment and reducing reliance on antibiotics are important considerations.
The USA occupies 37.4% of market share in 2022 globally. The pharmaceutical industry plays a crucial role in the moderate-to-severe acne treatment market in the United States. Several companies develop and market prescription medications specifically indicated for moderate-to-severe acne. These medications include topical formulations, oral medications, and combination therapies. The pharmaceutical market's dynamics, including competition and pricing, influence the availability and accessibility of acne treatments. This makes USA prominent market for moderate-to-severe acne treatment in North America.
Japan expenditure on moderate-to-severe acne treatment in 2022 was US$ 61.9 Million. Japan is at the forefront of technological advancements in the healthcare industry. Japan is known for its advancements in skincare technology and product development. The market offers a wide range of innovative acne treatment products, including topical formulations, skincare devices, and specialized cosmetics. Advanced technology and unique formulations contribute to the growth and competitiveness of the market.
Traditional and natural skincare approaches have a significant presence in the Japanese market. Some individuals with moderate-to-severe acne may seek alternative treatments, including herbal remedies, traditional medicine, and natural skincare products.
In 2022, the China held a significant share in the East Asia market and is expected to present lucrative growth of 6.1% CAGR over the forecast period. China has a thriving e-commerce market, and online platforms play a significant role in the distribution and sales of skincare products, including acne treatments. Online shopping platforms provide convenience and accessibility, allowing individuals to access a wide range of products for moderate-to-severe acne treatment.
Chinese consumers are becoming more educated about skincare and are increasingly focused on maintaining healthy and clear skin. They are receptive to innovative skincare products and treatment options, including those targeted at moderate-to-severe acne.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By treatment, retinoid therapy held 25.6% market share in world in 2022.
The moderate-to-severe acne treatment market, specifically focusing on retinoid therapy, is a significant segment within the dermatology market. Retinoids are a class of medications derived from vitamin A that are commonly used in the treatment of acne. They work by reducing inflammation, promoting skin cell turnover, and preventing the formation of comedones.
Retinoids, including topical retinoids like tretinoin, adapalene, and tazarotene, have been proven to be highly effective in treating moderate-to-severe acne. Their ability to target multiple aspects of acne pathogenesis contributes to their popularity and market demand.
The market value of topical mode is US$ 574.3 Million, representing a sizable 46.1% market share in 2022. The moderate-to-severe acne treatment market, with a focus on topical treatments, plays a crucial role in addressing the needs of individuals with more severe forms of acne. Topical treatments are applied directly to the skin and can include various formulations and active ingredients targeting acne symptoms and underlying causes.
Combination topical therapies are commonly prescribed for moderate-to-severe acne. These combinations may include a combination of active ingredients such as retinoids, benzoyl peroxide, antibiotics, or azelaic acid. Combining different agents with complementary mechanisms of action can provide enhanced efficacy in managing acne symptoms.
The hospitals have a considerable presence in the moderate-to-severe acne treatment market, accounting for 34.9% value share in 2022, and exhibiting a high CAGR of 5.2% over the forecast period. In some cases, individuals with severe acne may require hospitalization for intensive treatment. This is typically reserved for cases where acne is causing significant physical or psychological distress and requires specialized care. Inpatient dermatology services in hospitals can provide a multidisciplinary approach to managing severe acne.
Some hospitals have specialized dermatology departments equipped with phototherapy units and laser devices. These treatments can be used in the management of moderate-to-severe acne, particularly for patients who have not responded well to conventional therapies.
Various firms active within the acne treatment industry are actively seeking collaborations with healthcare providers, and research institutions to can encourage innovation. Introduction of new and effective treatment modalities has been emphasized a lot.
Similarly, recent developments related to the companies active within the moderate-to-severe acne treatment have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Market Segments Covered | Treatment, Route of Administration, Distribution Channel and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The market size of moderate-to-severe acne treatment is US$ 1.3 billion in 2023.
The market is expected to expand at a CAGR of 6.2%.
Increasing investment in therapies and products and social impact of acne.
The most effective acne treatment is retinoid therapy.
The United States holds massive portion of the market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Treatment Adoption / Usage Analysis
4.2. Reimbursement Scenario
4.3. Regulatory Landscape
4.4. PESTEL Analysis
4.5. Porter’s Analysis
4.6. Patient Treatment Regime
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Increasing Cases of Skin Disorders
5.2.3. Favourable Government Regulations
5.2.4. Rising Demand for Topical Treatments
5.2.5. Technological Advancement in the Moderate-to-Severe Acne Treatment
5.2.6. Increasing Prevalence of Acne Vulgaris
5.2.7. Growing Demand for Laser based Treatments
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
6.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Treatment
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Treatment, 2017 to 2022
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033
7.3.1. Antibiotics
7.3.2. Retinoid Therapy
7.3.3. Hormonal Drugs
7.3.4. Anti-Inflammatory Drugs
7.3.5. Chemical Peels
7.3.6. Laser Devices
7.3.7. Radiofrequency Devices
7.4. Market Attractiveness Analysis By Treatment
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Route of Administration
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Route of Administration, 2017 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
8.3.1. Oral
8.3.2. Topical
8.3.3. Injectables
8.4. Market Attractiveness Analysis By Route of Administration
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Pharmacies & Drug Stores
9.3.4. e-Commerce
9.3.5. Others
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East & Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
11.3.1. By Country
11.3.1.1. USA
11.3.1.2. Canada
11.3.2. By Treatment
11.3.3. By Route of Administration
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Treatment
11.4.3. By Route of Administration
11.4.4. By Distribution Channel
11.5. Country Level Analysis & Forecast
11.5.1. USA Market Analysis
11.5.1.1. Introduction
11.5.1.2. Market Analysis and Forecast by Market Taxonomy
11.5.1.2.1. By Treatment
11.5.1.2.2. By Route of Administration
11.5.1.2.3. By Distribution Channel
11.5.2. Canada Market Analysis
11.5.2.1. Introduction
11.5.2.2. Market Analysis and Forecast by Market Taxonomy
11.5.2.2.1. By Treatment
11.5.2.2.2. By Route of Administration
11.5.2.2.3. By Distribution Channel
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Treatment
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Treatment
12.4.3. By Route of Administration
12.4.4. By Distribution Channel
12.5. Country Level Analysis & Forecast
12.5.1. Brazil Market Analysis
12.5.1.1. Introduction
12.5.1.2. Market Analysis and Forecast by Market Taxonomy
12.5.1.2.1. By Treatment
12.5.1.2.2. By Route of Administration
12.5.1.2.3. By Distribution Channel
12.5.2. Mexico Market Analysis
12.5.2.1. Introduction
12.5.2.2. Market Analysis and Forecast by Market Taxonomy
12.5.2.2.1. By Treatment
12.5.2.2.2. By Route of Administration
12.5.2.2.3. By Distribution Channel
12.5.3. Argentina Market Analysis
12.5.3.1. Introduction
12.5.3.2. Market Analysis and Forecast by Market Taxonomy
12.5.3.2.1. By Treatment
12.5.3.2.2. By Route of Administration
12.5.3.2.3. By Distribution Channel
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. France
13.3.1.3. Italy
13.3.1.4. UK
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. BENELUX
13.3.1.8. Rest of Europe
13.3.2. By Treatment
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Treatment
13.4.3. By Route of Administration
13.4.4. By Distribution Channel
13.5. Country Level Analysis & Forecast
13.5.1. Germany Market Analysis
13.5.1.1. Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Treatment
13.5.1.2.2. By Route of Administration
13.5.1.2.3. By Distribution Channel
13.5.2. France Market Analysis
13.5.2.1. Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Treatment
13.5.2.2.2. By Route of Administration
13.5.2.2.3. By Distribution Channel
13.5.3. Italy Market Analysis
13.5.3.1. Introduction
13.5.3.2. Market Analysis and Forecast by Market Taxonomy
13.5.3.2.1. By Treatment
13.5.3.2.2. By Route of Administration
13.5.3.2.3. By Distribution Channel
13.5.4. UK Market Analysis
13.5.4.1. Introduction
13.5.4.2. Market Analysis and Forecast by Market Taxonomy
13.5.4.2.1. By Treatment
13.5.4.2.2. By Route of Administration
13.5.4.2.3. By Distribution Channel
13.5.5. Spain Market Analysis
13.5.5.1. Introduction
13.5.5.2. Market Analysis and Forecast by Market Taxonomy
13.5.5.2.1. By Treatment
13.5.5.2.2. By Route of Administration
13.5.5.2.3. By Distribution Channel
13.5.6. Russia Market Analysis
13.5.6.1. Introduction
13.5.6.2. Market Analysis and Forecast by Market Taxonomy
13.5.6.2.1. By Treatment
13.5.6.2.2. By Route of Administration
13.5.6.2.3. By Distribution Channel
13.5.7. BENELUX Market Analysis
13.5.7.1. Introduction
13.5.7.2. Market Analysis and Forecast by Market Taxonomy
13.5.7.2.1. By Treatment
13.5.7.2.2. By Route of Administration
13.5.7.2.3. By Distribution Channel
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Treatment
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Treatment
14.4.3. By Route of Administration
14.4.4. By Distribution Channel
14.5. Country Level Analysis & Forecast
14.5.1. India Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Treatment
14.5.1.2.2. By Route of Administration
14.5.1.2.3. By Distribution Channel
14.5.2. Thailand Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Treatment
14.5.2.2.2. By Route of Administration
14.5.2.2.3. By Distribution Channel
14.5.3. Indonesia Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Treatment
14.5.3.2.2. By Route of Administration
14.5.3.2.3. By Distribution Channel
14.5.4. Malaysia Market Analysis
14.5.4.1. Introduction
14.5.4.2. Market Analysis and Forecast by Market Taxonomy
14.5.4.2.1. By Treatment
14.5.4.2.2. By Route of Administration
14.5.4.2.3. By Distribution Channel
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Treatment
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Treatment
15.4.3. By Route of Administration
15.4.4. By Distribution Channel
15.5. Country Level Analysis & Forecast
15.5.1. China Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Treatment
15.5.1.2.2. By Route of Administration
15.5.1.2.3. By Distribution Channel
15.5.2. Japan Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Treatment
15.5.2.2.2. By Route of Administration
15.5.2.2.3. By Distribution Channel
15.5.3. South Korea Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Treatment
15.5.3.2.2. By Route of Administration
15.5.3.2.3. By Distribution Channel
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Treatment
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Treatment
16.4.3. By Route of Administration
16.4.4. By Distribution Channel
16.5. Country Level Analysis & Forecast
16.5.1. Australia Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Treatment
16.5.1.2.2. By Route of Administration
16.5.1.2.3. By Distribution Channel
16.5.2. New Zealand Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Treatment
16.5.2.2.2. By Route of Administration
16.5.2.2.3. By Distribution Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Türkiye
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Treatment
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Treatment
17.4.3. By Route of Administration
17.4.4. By Distribution Channel
17.5. Country Level Analysis & Forecast
17.5.1. GCC Countries Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Treatment
17.5.1.2.2. By Route of Administration
17.5.1.2.3. By Distribution Channel
17.5.2. Türkiye Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Treatment
17.5.2.2.2. By Route of Administration
17.5.2.2.3. By Distribution Channel
17.5.3. Northern Africa Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Treatment
17.5.3.2.2. By Route of Administration
17.5.3.2.3. By Distribution Channel
17.5.4. South Africa Market Analysis
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Treatment
17.5.4.2.2. By Route of Administration
17.5.4.2.3. By Distribution Channel
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Branding and Promotional Strategies, By Key Players
19.3. Key Development Analysis
19.4. Competition Deep Dive
19.4.1. Johnson & Johnson
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Key Financials
19.4.1.4. Sales Footprint
19.4.1.5. SWOT Analysis
19.4.1.6. Strategy Overview
19.4.1.6.1. Marketing Strategy
19.4.1.6.2. Product Strategy
19.4.1.6.3. Channel Strategy
19.4.2. Bayer AG
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Key Financials
19.4.2.4. Sales Footprint
19.4.2.5. SWOT Analysis
19.4.2.6. Strategy Overview
19.4.2.6.1. Marketing Strategy
19.4.2.6.2. Product Strategy
19.4.2.6.3. Channel Strategy
19.4.3. Galderma
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Key Financials
19.4.3.4. Sales Footprint
19.4.3.5. SWOT Analysis
19.4.3.6. Strategy Overview
19.4.3.6.1. Marketing Strategy
19.4.3.6.2. Product Strategy
19.4.3.6.3. Channel Strategy
19.4.4. Allergan
19.4.4.1. Overview
19.4.4.2. Product Portfolio
19.4.4.3. Key Financials
19.4.4.4. Sales Footprint
19.4.4.5. SWOT Analysis
19.4.4.6. Strategy Overview
19.4.4.6.1. Marketing Strategy
19.4.4.6.2. Product Strategy
19.4.4.6.3. Channel Strategy
19.4.5. Roche
19.4.5.1. Overview
19.4.5.2. Product Portfolio
19.4.5.3. Key Financials
19.4.5.4. Sales Footprint
19.4.5.5. SWOT Analysis
19.4.5.6. Strategy Overview
19.4.5.6.1. Marketing Strategy
19.4.5.6.2. Product Strategy
19.4.5.6.3. Channel Strategy
19.4.6. Valeant Pharmaceuticals
19.4.6.1. Overview
19.4.6.2. Product Portfolio
19.4.6.3. Key Financials
19.4.6.4. Sales Footprint
19.4.6.5. SWOT Analysis
19.4.6.6. Strategy Overview
19.4.6.6.1. Marketing Strategy
19.4.6.6.2. Product Strategy
19.4.6.6.3. Channel Strategy
19.4.7. Stiefel Laboratories
19.4.7.1. Overview
19.4.7.2. Product Portfolio
19.4.7.3. Key Financials
19.4.7.4. Sales Footprint
19.4.7.5. SWOT Analysis
19.4.7.6. Strategy Overview
19.4.7.6.1. Marketing Strategy
19.4.7.6.2. Product Strategy
19.4.7.6.3. Channel Strategy
19.4.8. Pfizer
19.4.8.1. Overview
19.4.8.2. Product Portfolio
19.4.8.3. Key Financials
19.4.8.4. Sales Footprint
19.4.8.5. SWOT Analysis
19.4.8.6. Strategy Overview
19.4.8.6.1. Marketing Strategy
19.4.8.6.2. Product Strategy
19.4.8.6.3. Channel Strategy
19.4.9. Foamix Pharmaceuticals
19.4.9.1. Overview
19.4.9.2. Product Portfolio
19.4.9.3. Key Financials
19.4.9.4. Sales Footprint
19.4.9.5. SWOT Analysis
19.4.9.6. Strategy Overview
19.4.9.6.1. Marketing Strategy
19.4.9.6.2. Product Strategy
19.4.9.6.3. Channel Strategy
19.4.10. La Roche-Posay
19.4.10.1. Overview
19.4.10.2. Product Portfolio
19.4.10.3. Key Financials
19.4.10.4. Sales Footprint
19.4.10.5. SWOT Analysis
19.4.10.6. Strategy Overview
19.4.10.6.1. Marketing Strategy
19.4.10.6.2. Product Strategy
19.4.10.6.3. Channel Strategy
19.4.11. Proactiv
19.4.11.1. Overview
19.4.11.2. Product Portfolio
19.4.11.3. Key Financials
19.4.11.4. Sales Footprint
19.4.11.5. SWOT Analysis
19.4.11.6. Strategy Overview
19.4.11.6.1. Marketing Strategy
19.4.11.6.2. Product Strategy
19.4.11.6.3. Channel Strategy
19.4.12. Cipla Limited
19.4.12.1. Overview
19.4.12.2. Product Portfolio
19.4.12.3. Key Financials
19.4.12.4. Sales Footprint
19.4.12.5. SWOT Analysis
19.4.12.6. Strategy Overview
19.4.12.6.1. Marketing Strategy
19.4.12.6.2. Product Strategy
19.4.12.6.3. Channel Strategy
19.4.13. GlaxoSmithKline Inc.
19.4.13.1. Overview
19.4.13.2. Product Portfolio
19.4.13.3. Key Financials
19.4.13.4. Sales Footprint
19.4.13.5. SWOT Analysis
19.4.13.6. Strategy Overview
19.4.13.6.1. Marketing Strategy
19.4.13.6.2. Product Strategy
19.4.13.6.3. Channel Strategy
19.4.14. Janssen Pharmaceuticals Inc.
19.4.14.1. Overview
19.4.14.2. Product Portfolio
19.4.14.3. Key Financials
19.4.14.4. Sales Footprint
19.4.14.5. SWOT Analysis
19.4.14.6. Strategy Overview
19.4.14.6.1. Marketing Strategy
19.4.14.6.2. Product Strategy
19.4.14.6.3. Channel Strategy
19.4.15. Sanofi
19.4.15.1. Overview
19.4.15.2. Product Portfolio
19.4.15.3. Key Financials
19.4.15.4. Sales Footprint
19.4.15.5. SWOT Analysis
19.4.15.6. Strategy Overview
19.4.15.6.1. Marketing Strategy
19.4.15.6.2. Product Strategy
19.4.15.6.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Moderate-to-Severe Acne Treatment Market
